VEGFC and neoplasm: Phage display was even used against mutated forms of VEGF [66], or VEGF-C [67] and in vivo, to identify tumor-homing peptides that specifically target tumor blood vessels, with the potential to improve the systemic treatment of patients with solid tumors [68].